Morten Nielsen

Subcuject is a medical device company developing and commercializing an innovative and proprietary platform for subcutaneous Wearable Bolus Injection - the Subcuject WBI. The device platform applies osmosis as driving force, and offers a unique combination of low cost, friendliness for patients and design for pharma company drug integration as a combination product. Subcuject collaborates with Phillips-Medisize on development, manufacturing and commercialization of drug specific combination products

Rehaler A/S is a medical technology company developing innovative treatments for central nervous system disorders

Welcome to Nielsen Advisory. We are a small focused consultancy offering Board and Executive Consulting Services with a primary focus on the MedTech industry. Our Services are based on more than 25 years of experience across various industries. The Company was established in august 2019 and is owned by Morten Nielsen. Morten Nielsen has an extensive Executive leadership, Operational and Industry experience base with a fovus in MedTech (refer below). Hesdline CV for Morten Nielsen 2018-2019 VP, Phillips-Medisize A/S 2011-2018, CEO, Medicom Innovation Partner A/S 2001-2011, Partner, PA Consulting Group 2000-2001, Owner, Procata Consulting 1998-2000, Business Development Manager, Intentia Denmark A/S (formerly Lawson, today Infor M3) 1996- 1998, Corporate Process and QA Manager, Olicom A/S (now part of Intel) 1995-1996: Manager, Active Medical Devices, DGM A/S (Danish Medical Devices Certification) 1992-1995: Regulatory Engineer, S&W Medico Teknik A/S 1991: M.Sc.E.E, major in Biomedical Engineering (Aalborg University)

Welcome to Nielsen Advisory. We are a small focused consultancy offering Board and Executive Consulting Services with a primary focus on the MedTech industry. Our Services are based on more than 25 years of experience across various industries. The Company was established in august 2019 and is owned by Morten Nielsen. Morten Nielsen has an extensive Executive leadership, Operational and Industry experience base with a fovus in MedTech (refer below). Hesdline CV for Morten Nielsen 2018-2019 VP, Phillips-Medisize A/S 2011-2018, CEO, Medicom Innovation Partner A/S 2001-2011, Partner, PA Consulting Group 2000-2001, Owner, Procata Consulting 1998-2000, Business Development Manager, Intentia Denmark A/S (formerly Lawson, today Infor M3) 1996- 1998, Corporate Process and QA Manager, Olicom A/S (now part of Intel) 1995-1996: Manager, Active Medical Devices, DGM A/S (Danish Medical Devices Certification) 1992-1995: Regulatory Engineer, S&W Medico Teknik A/S 1991: M.Sc.E.E, major in Biomedical Engineering (Aalborg University)

EYE-GO A/S is a Danish MedTech start-up established 2015 based on the work by two designers wanting to develop eye-care technologies that improve the quality of life of people around the world suffering from severe and chronic eye conditions. Problem: Only a fraction of patients achieves the full health outcome of treatment due to imperfections with current eye drop bottles. Users experience difficulties instilling the medication, over-dose due to drop size, side-effects and may abandon prescribed treatment plan leading to poor disease management. This is not just an issue for patients who best case loose quality of life and worst case may end up blind, but also for pharma companies whose drugs don’t have full therapeutic effect, and society ending up with unnecessary high health care spending. Solution: MistGo® is a new generation micro-dosing drug delivery system mitigating the imperfections with current eye-drop bottles. MistGo® makes it simple and comfortable to self-administer the drug correctly with the precisely required amount of drug entering the eye at first go, and helps patients adhere to treatment long-term This cutting-edge eye treatment technology from EYE-GO is suitable for long-term eye care diseases requiring topical ocular treatment and is compatible with preservative-free liquids. Leading ophthalmologists and frontrunning international industry players have already name it an “an ophthalmologic game changer”. Visit our website to learn more, or contact us now on HNA@EYE-GO.com (Henrik Nagel, CEO) or RS@EYE-GO.com (Rie Saabye, Director Business Development) to discuss licensing opportunities of an innovative drug delivery system for one or more of your innovative substances.

SPT VILECON is a dynamic consultancy company under Danish ownership. We offer specialist consultancy, concepts and development, construction and production of devices, primarily for the medical and pharmaceutical industries. We focus on developing new products and improving/optimising existing products in close dialogue with our customers and partners. Our customers are often the leading international companies in their specific field. SPT VILECON is actively involved in every phase of development from concept to finished product. We can, however, also assume responsibility only for parts of a project. Since SPT & VILECON was founded in 2011, the company has grown fast. We are a team of dedicated engineers, technicians and sales representatives, all of whom are highly qualified within their specific professions. We are enthusiastic, we are proud of what we do and we are passionate about our work. We have strong competences at our disposal within many areas, including product development, business development, project management, patent applications, injection moulding, metrology, technical sales, Lean/Six Sigma and supply chain management. We have in-house production facilities, including test equipment and plastic injection moulding machinery at our disposal. This means that we can start up and test complete production units before they are delivered to the customer.

ChangeGroup empowers Danish businesses and institutions to achieve and maintain a competitive edge in todays digital landscape. Our expert advice on IT and digitalization strategies, tailored to the specific needs of each clients business and organizational culture, allows them to optimize their operations and stay ahead of the curve. With our focus on assembling top-performing teams and driving digitalization through collaborative teamwork and innovative thinking, we help drive the digital transformation of Denmarks economy.

Innovation Fund Denmark connects research, knowledge and ideas with the businesses and society that need them.

Subcuject is a medical device company developing and commercializing an innovative and proprietary platform for subcutaneous Wearable Bolus Injection - the Subcuject WBI. The device platform applies osmosis as driving force, and offers a unique combination of low cost, friendliness for patients and design for pharma company drug integration as a combination product. Subcuject collaborates with Phillips-Medisize on development, manufacturing and commercialization of drug specific combination products